Amlan Chakraborty
I have completed my PhD from Department of Immunology, Monash University on the development of novel immunomodulators for the treatment of acute respiratory distress syndrome (ARDS). My research interest is in the development of drug conjugated nanoparticles to target airway inflammatory diseases such as asthma and ARDS as well as fibrotic diseases such as idiopathic pulmonary fibrosis.
Abstracts this author is presenting:
